Product: 98.5% Min. Gatifloxacin
CAS No.:112811-59-3
Other Names: Gatifloxacin
MF: C19H22FN3O4
Place of Origin: Jiangxi, China
Product Details
Our organization successfully attained IS9001 Certification and European CE Certification of Heparin Sodium Bp Usp, Intermediates 2,3,4-Trihydroxybenzophenone, Methyl cinnamate. We have a professional, efficiency team to provide quality service for our customer. Our company sets up several departments, including production department, sales department, quality control department and sevice center, etc. We will adhere to the concept of 'innovation, efficiency, unity, and integrity', operate steadily and continue to provide customers with better products and more considerate services. The key to the true core competitive advantage of an enterprise is to create greater service value for customers, therefore we are working hard to develop more products for customers to choose from.
Product: 98.5% Min. Gatifloxacin
CAS No.:112811-59-3
Other Names: Gatifloxacin
MF: C19H22FN3O4
Place of Origin: Jiangxi, China
Type: Antibiotic and Antimicrobial Agents
Grade Standard: Medicine Grade
Usage: Animal Pharmaceuticals
Brand Name: RQK Pharm
Model Number: Top Grade
Purity: 99%min
Color: white
Shelf life: 2 Years Proper Storage
MW: 375.3941
Appearance: Powder
Application: medicine
Density: 1.386 g/cm3
Standard: BP USP EP
Storage: Dry Place
Melting point: 162°C
Packaging & Delivery
Packaging Details:
1kg with double plastic container inside/Aluminum foil bag
25kg with double plastic container inside/Fiber drum outside. Or as your request.
Delivery Time:Shipped in 3 days after payment
We are determined to become the most trusted supplier of Gatifloxacin Tablets 100mg GMP for users, insisting on technological innovation as the driving force, market demand as the guidance, continuous innovation, and improving the economic and social benefits of the enterprise. Our company adheres to the business philosophy of 'people-oriented, pursuit of excellence, realistic innovation, and service to the society'. Our company will, as always, be demand-oriented, and take research and development as our driving force.